Labshake search

1 - 11 of 11 citations for Pirimiphos methyl since 2019

• An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory

  Ole A.W. Haabeth, et al., bioRxiv - Immunology 2021

  Quote: ... N1-methyl-pseudouridine (Trilink) and 5-Methylcytidine (Trilink) ...
• SRSF2 regulation of MDM2 reveals splicing as a therapeutic vulnerability of the p53 pathway

  Daniel F. Comiskey Jr., et al., bioRxiv - Cancer Biology 2019

  Quote: 2’O-methyl SSOs were provided by Trilink BioTechnologies ...
• MAGIK: A rapid and efficient method to create lineage-specific reporters in human pluripotent stem cells

  Tahir Haideri, et al., bioRxiv - Bioengineering 2023

  Quote: ... 12.5 mM N1-methyl-pseudo-UTP (TriLink Biotechnologies), and 10 mM CleanCap AG (TriLink Biotechnologies) ...
• Extensive N4 Cytosine Methylation is Essential for Marchantia Sperm Function

  James Walker, et al., bioRxiv - Developmental Biology 2021

  Quote: ... PCR product synthesized with N4-methyl-dCTP (4mdCTP; Trilink) using primers JZ294/JZ295 (Table S5 ...
• Interaction of modified oligonucleotides with nuclear proteins, formation of novel nuclear structures and sequence-independent effects on RNA processing

  Loren L Flynn, et al., bioRxiv - Molecular Biology 2019

  Quote: ... and 2’ O-methyl phosphorothioate AOs were synthesised by TriLink BioTechnologies (San Diego CA ...
• Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques

  Lulu Huang, et al., bioRxiv - Immunology 2024

  Quote: ... Methyl-pseudouridine (SYNTHGENE)-modified mRNAs were capped using Cap1 Analogue Reagent (TriLink) and further purified by Monarch RNA purification columns (NEB ...
• A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression

  Huajun Zhao, et al., bioRxiv - Immunology 2023

  Quote: ... mRNAs were modified with N1-Methyl-pseudouridine (Synthgene) and capped using CleanCap Reagent (TriLink). After this ...
• Massively parallel base editing screens to map variant effects on anti-tumor hallmarks of primary human T cells

  Zachary H. Walsh, et al., bioRxiv - Immunology 2023

  Quote: ... with substitution of N-1-methyl-pseudouridine-5’-triphosphate (TriLink Biotechnologies, #N-1081-1) for UTP and co-transcriptional capping with CleanCap® Reagent AG (TriLink Biotechnologies ...
• Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants

  I-Jung Lee, et al., bioRxiv - Microbiology 2022

  Quote: ... for co-transcriptional capping of mRNA and complete replacement of uridine by N1-methyl-pseudouridine (Trilink, CA, USA). The mRNA was purified by LiCl (Invitrogen ...
• Directed Evolution of Adenine Base Editors with Increased Activity and Therapeutic Application

  Nicole M. Gaudelli, et al., bioRxiv - Genomics 2020

  Quote: ... The NEB HiScribe High-Yield Kit was used as per the instruction manual but with full substitution of N1-methyl-pseudouridine for uridine and co-transcriptional capping with CleanCap AG (Trilink). Reaction cleanup was performed by lithium chloride precipitation ...
• Programmable large DNA deletion, replacement, integration, and inversion with twin prime editing and site-specific recombinases

  Andrew V. Anzalone, et al., bioRxiv - Genomics 2021

  Quote: ... was used according to the company’s recommended instruction but with full substitution of N1-methyl-pseudouridine for uridine and co-transcriptional capping with CleanCap AG (TriLink Biotechnologies). RNA was precipitated with lithium chloride (2.5 M final concentration) ...